https://www.selleckchem.com/pr....oducts/anlotinib-al3
Validation of the differential expression was performed via qRT-PCR and immunoblot analysis in the defined model nerve cell line and primary mouse neurons. Further verification was performed using immunocytochemistry. In conclusion, we identified apparent changes in gene expression on Aβ treatment in the presence of the sensitizing nAChRs, linked to early-stage Aβ-induced neurotoxicity, which may represent novel therapeutic targets.Interacting electrons confined in one dimension are generally described by the Luttinger liquid f
Aimer
Commentaire
Partagez
